Le Labo China: Foreign Beauty's Comeback Belongs to the Niche, Not the Giants
- 8 hours ago
- 6 min read
The most instructive foreign beauty store in China right now is 50 square metres. It sits at No 135 Wukang Road in Shanghai, inside a grey-and-white heritage villa, and it is not really a Le Labo store at all. It is a shared space with Gathering, a Chinese artisan label selling Jingdezhen ceramics and vintage furniture. A perfume blending room sits next to a porcelain gallery. In its first month, the store averaged more than 2,000 visitors a day, and on weekends drew more traffic than Le Labo's own flagship in Xintiandi.
That is a strange result for a brand owned by the world's second largest prestige beauty group. It is also, we think, the single clearest picture of what is working for foreign beauty in China in 2026, and of what is not.
The recovery is real. The headline about it is wrong.
For three years the received wisdom has been that foreign beauty is losing China. That story is now out of date. Estee Lauder's mainland China net sales rose 13% to US$928 million in its fiscal 2026 second quarter, a second consecutive quarter of double-digit retail sales growth, led by La Mer, TOM FORD and Le Labo. The group gained share in every category in China across both brick-and-mortar and online.
L'Oreal tells the same story from the other end. Reported North Asia sales fell 9.0% to 2.69 billion euros in the first quarter of 2026, yet L'Oreal Luxe delivered high single digit growth in China, Dermatological Beauty grew in double digits, and Aesop was singled out as a very strong contributor, while the Consumer Products division managed only a stabilisation in sell-out in a market it describes as soft and highly competitive.
Read those two sets of numbers together and the pattern is hard to miss. Both giants are growing in China through their least giant assets. The engines are a cult perfumer, a US$500 face cream, an Australian apothecary brand and a dermatological range. The mass megabrands that built these companies are, at best, holding still.
This is not a story about big versus small. It is a story about niche versus scale, and the niche side of that trade is currently winning inside the giants themselves.
What Le Labo China reveals about scale
Le Labo entered mainland China in 2023 with a two-storey flagship in a shikumen building in Xintiandi, a former Old Shanghai museum converted into a store with a vegan bakery attached. The brand did not arrive with a category strategy or a price ladder. It arrived with a building.
The Wukang Road store went further. Rather than open a second boutique in a mall, Le Labo China took residence inside someone else's cultural space, and let a Chinese artisan brand keep top billing. A calligraphy piece reading Shi Yi, Shanghainese for being at ease, hangs on the wall. This is not localisation in the usual sense, where a brand adds a Lunar New Year gift box and a Chinese ambassador. It is co-authorship, and it is much harder to fake.
The economics are worth sitting with. Fifty square metres. Shared rent. No department store counter, no beauty advisor army, no 618 discount ladder. And it out-pulls a flagship on weekends. Le Labo China did not win by outspending anyone. It won by being the kind of place a Xiaohongshu user wants to photograph and explain to her followers.
Aesop, now inside L'Oreal, runs the same logic: architecture-led stores, no discounting, no celebrity face. Both brands are essentially selling a point of view, and China's high-income consumer is currently paying more for a point of view than for a heritage logo.
Why the mass playbook stopped working
The foreign mass playbook in China had three legs: brand awareness bought through TV and platform advertising, distribution bought through Tmall and JD, and volume bought through Double 11 discounts. All three legs have been kicked out.
Awareness is now earned in content, not bought in media. Distribution is crowded with domestic brands that iterate faster and price lower. And discounting is a losing arms race against companies with shorter supply chains. L'Oreal's own commentary is blunt about it: in North Asia the Consumer Products division is stabilising, not growing. Shiseido, which bet more heavily on China than either peer, cut sales by 2.1% in 2025, posted a reported operating loss of 28.8 billion yen, and saw its China and travel retail sales fall 4.3%.
We have seen this pattern outside beauty too. Lululemon's premium bet in China started cracking in 2026 for a similar reason: a foreign brand can hold a premium price only for as long as it holds a story the local competition cannot tell. Once the story becomes generic, price is all that is left, and price is the one fight foreign brands cannot win in China.
There is a category dimension as well. Chinese and European consumers do not use the same language to talk about skincare, and the efficacy-first vocabulary that dominates China rewards dermatological brands and punishes vague positioning. That is exactly why L'Oreal's Dermatological Beauty is compounding in double digits in North Asia while its mass skincare is not.
The channel stack an independent brand can actually afford
Here is the part that matters for brands without a group behind them. The model that is working for Le Labo China and Aesop no longer requires a giant's balance sheet. It requires three things, and all three are now available to an independent.
First, Xiaohongshu, the lifestyle platform often described as China's Instagram crossed with a review site. It is the one Chinese channel where a brand gets to explain itself before it gets compared on price. For a niche foreign brand with a genuine story, that sequencing is everything. For a mass brand with no story, Xiaohongshu is a liability.
Second, multi-brand retail. China's beauty retail landscape is unusually hostile to conventional chains, a structural problem we have written about before, but the discovery-led formats have thrived. Harmay is the clearest case: it opened its first store in 2017, built stores that function as much like galleries as shops, and raised US$200 million from investors including General Atlantic to broaden its brand portfolio and open stores in Wuhan, Guangzhou and Shenzhen. For a foreign independent, one shelf in that kind of retailer buys more credibility than a Tmall flagship store bought with the same money.
Third, category timing. Fragrance in China has moved from a functional purchase to an identity purchase, and capital is chasing what executives now call the fragrance economy. The Estee Lauder Companies has taken a minority stake in the homegrown Chinese label Melt Season, and L'Oreal has invested in To Summer, while Proya, Kans and Mao Geping have all entered the category this year. When the giants are buying into a category rather than dominating it, the category is still open.
What we would watch from here
Two cautions. The first is that niche does not automatically scale. Le Labo China works partly because it is small and scarce, and scarcity is a resource that depletes as you open stores. The interesting question for Estee Lauder is not whether Le Labo grows in China, but at what store count the magic stops.
The second is that the model is easy to imitate badly. A heritage villa, a calligraphy scroll and a collaboration with a local craftsman are the visible outputs of a decision that was made much earlier, which is that the brand had something specific to say. Brands that copy the outputs without having made that decision end up with an expensive stage set and no play.
For the founders we work with, the practical read is this. The China question in 2026 is no longer whether a foreign brand can win. It is whether the brand is distinct enough to be worth discovering. If it is, the channel stack is cheaper and more forgiving than it has been in a decade. If it is not, no amount of media spend will fix it, and the giants have already proved that at scale.
Double V is a cross-border operating partner and intelligence house for emerging consumer brands, based in Hong Kong and Shenzhen. We help brands connect China and the world through three businesses: Brand Operation (marketing and distribution for brands on retainer), Brand Incubation (sister company Glam Infinite and our own-built brands), and Industry Intelligence (cross-border research and reports). Talk to our team.